Content about DARMSTADT

October 11, 2012

Merck KGaA to donate $1.3 million per year to academic MS research

A German drug maker is pledging millions of dollars for multiple sclerosis research, the company's U.S. subsidiary said Thursday.

June 6, 2012

Dr. Reddy's, Merck KGaA partner on biosimilars

A generic drug maker in India and a German pharmaceutical company will collaborate to develop biosimilars.

October 6, 2011

Merck KGaA, Ono sign agreement for oral MS, cancer drugs

German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.

September 8, 2011

Robert Yates to lead Merck KGaA's life science division

Merck KGaA announced that Robert Yates was named president of Merck Millipore, the drug maker's life science division.

August 4, 2011

Merck KGaA completes enrollment in late-stage trial for Parkinson's disease drug

German drug maker Merck KGaA said it finished enrolling patients in a late-stage clinical study of a drug for Parkinson's disease.

July 7, 2011

Merck Serono names new COO

Merck KGaA division Merck Serono has appointed Belen Garijo as COO and Annalisa Jenkins as global head of drug development and medical, effective Sept. 5.

March 3, 2011

Merck receives CRL for MS treatment

The Food and Drug Administration declined to approve a Merck KGaA drug designed to treat relapsing-remitting multiple sclerosis.

July 15, 2010

Millipore officially becomes part of Merck KGaA

German drug maker Merck KGaA has finished acquiring U.S. life-sciences company Millipore, Merck KGaA said...

February 28, 2010

Merck buys Millipore

Merck KGaA plans to buy a Massachusetts life sciences company for $7.2 billion, the German...